Legend Biotech Corporation IPO Research Information

Legend Biotech Corporation IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Legend Biotech Corporation, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Legend Biotech Corporation	LEGN - NASDAQ	$18.00-$20.00	$23.00	$37.00	18.4 million	6/5/2020
Underwriter(s): Morgan Stanley, JP Morgan, Jefferies
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2020-05-13 Terms Added 2020-05-29

Legend Biotech Corporation Quote & Chart - Click for current quote - LEGN

About Legend Biotech Corporation (adapted from Legend Biotech Corporation prospectus):
They are a global, clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "LEGN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.